• 1.
    Hartung T, King NMP, Kleinstreuer N, Leist M, Tagle DA. Leveraging biomarkers and translational medicine for preclinical safety – Lessons for advancing the validation of alternatives to animal testing. ALTEX. 2024;41(4):545–66. READ


  • 2.
    Hartung T.. The validation of regulatory test methods – Conceptual, ethical, and philosophical foundations. ALTEX. 2024;41(4):525–44. READ


  • 3.
    Gurjanov A, Vaas LAI, Steger-Hartmann T. The road to virtual control groups and the importance of proper body-weight selection. ALTEX. 2024;41(4):660-665. READ


  • 4.
    Sanz F, Pognan F, Steger-Hartmann T, Díaz C, et al. eTRANSAFE: data science to empower translational safety assessment. Nat Rev Drug Discov. 2023 Aug;22(8):605-606. READ


  • 5.
    Mecklenburg L, Lenz S, Hempel G. How important are concurrent vehicle control groups in (sub)chronic non-human primate toxicity studies conducted in pharmaceutical development? An opportunity to reduce animal numbers. PLoS One. 2023 Aug 3;18(8):e0282404. READ


  • 6.
    Steger-Hartmann T, Kreuchwig A, Vaas L, Wichard J, Bringezu F, Amberg A, Muster W, Pognan F, Barber C. Introducing the concept of virtual control groups into preclinical toxicology testing. ALTEX. 2020;37(3):343-349. READ